Skip to content
Screener

Pacira BioSciences, Inc. PCRX Q1 2026 earnings

Reported April 30, 2026 · After market close

Revenue$177.4MBeat by $5.6M
EPS$0.60Miss by $0.01
Revenue estimate$171.8M
EPS estimate$0.61

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$182.2M
EPS estimate$0.76

Financials

Q1 2026

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$915.07M-20.4%
Enterprise value$1.18B-3.4%
P/E178.1×—
P/S1.2×-0.4×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Segments

By product

See full
EXPAREL$143.3M+4.9%
ZILRETTA$26.8M+14.7%
iovera°$6.2M+20.6%
Bupivacaine liposome injectable suspension$1.2M-55.5%

By segment

See full
Reportable Segment$177.4M+5.0%

FAQ

When did Pacira BioSciences, Inc. report Q1 2026 earnings?
Pacira BioSciences, Inc. (PCRX) reported Q1 2026 earnings on April 30, 2026 after market close.
What were Pacira BioSciences, Inc.'s Q1 2026 revenue and EPS?
Pacira BioSciences, Inc. reported revenue of $177.4M and eps of $0.60 for Q1 2026.
Did Pacira BioSciences, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $171.8M by $5.6M. EPS missed the consensus estimate of $0.61 by $0.01.
How did Pacira BioSciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.0% from $168.9M a year earlier and eps declined 3.2% from $0.62.
Where can I find Pacira BioSciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-028854) and the 10-Q periodic report (0001628280-26-028871) directly on SEC EDGAR. The filing index links above go to sec.gov.